As support for medical marijuana grows and states consider proposals to legalize the drug for recreational use, advocates on both sides of the debate over whether to end the war on pot are pooling their collective resources to help push their agenda.
It’s no stretch to imagine, then, that the two industries best positioned to develop pot-based products—tobacco and pharmaceuticals—are also drafting playbooks to determine how they might capitalize on what CNBC.com estimates to be a $40-billion-a-year market.
“The tobacco companies are clearly in the best position to take their existing business model and employ cannabis and they have already privately thought to do so,” says Allen St. Pierre, executive director of Norml, an advocacy group for marijuana legislation reform. “These companies are well aware that they are sitting on a business model that needs only the acquiescence of the federal government.”
snip
Should lawmakers ever decide to legalize pot, tobacco and pharmaceutical companies would no doubt put research into overdrive to deliver a slew of THC-derived products to consumers, using the full strength of their financial muscle to dominate market share.
More...
http://www.cnbc.com/id/36177544
Printer-friendly format
Email this thread to a friend
Bookmark this thread
(379 posts)
Send PM |
Profile |
Ignore